An NNIT Group Company

Menu
  • Home
  • What We Do
    • Serialization Consulting
    • ERP Consulting
    • First Time Launch Services
    • EU/ROW Go-To Market
    • Quality & Validation
    • Brand Protection
  • How We Do It
    • Strategy / GAP Analysis
    • Implementation
    • Sustainability: Service Bureau
    • Packaged Services
      • Regulatory Radar Service
      • Healthcheck
      • Sustainability: Service Bureau
      • Partner & Customer Onboarding
      • Virtual-in-a-box
      • SOP Library
  • Industries
    • Pharma Manufacturers
    • Virtual Pharma/BioTech
    • Pharma – CMO/3PL
    • Retail Pharmacy & Healthcare
    • Wholesale Distributors
    • Other Regulated Industries
  • Global Track & Trace
  • Resources
    • Webinars
    • White Papers
    • News
  • About
    • Excellis Europe
    • Leadership
    • Working With Heroes
    • Designations & Awards
    • Contact
    • Careers

Daily Archives: May 19, 2020

FDA Guidance for COVID-19 Exemptions

Published on May 19, 2020

The FDA released a new guidance titled “Exemption and Exclusion from Certain Requirements of the Drug Supply Chain Security Act (DSCSA) During the COVID-19 Public Health Emergency” on April 30, 2020.

Read It Now

Recent Posts

  • Excellis’ CEO featured in NNIT white paper “The Factory of the Future is Fully Integrated”
  • Excellis’ Managing Consultant Featured in Brand Protection Book
  • Excellis and NNIT to participate in DIA Global Annual Meeting 2022
  • Jazz Pharmaceuticals Health Check and Brand Risk Assessment Case Study
  • NNIT Group Acquires Excellis Health Solutions

Subscribe for updates from Excellis



Copyright © 2023 Excellis Health Solutions.

4 East Bridge Street
New Hope, PA 18938

tel: 215-816-8125